Standard BioTools Inc.
LAB
$1.50
$0.074.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 194.90M | 237.09M | 258.06M | 292.87M | 366.33M |
| Total Receivables | 13.54M | 14.61M | 35.48M | 33.61M | 35.32M |
| Inventory | 25.42M | 24.17M | 42.13M | 40.74M | 42.64M |
| Prepaid Expenses | 7.91M | 7.08M | 8.35M | 8.66M | 9.32M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 230.68M | 223.09M | -- | -- | -- |
| Total Current Assets | 472.44M | 506.04M | 344.02M | 375.88M | 453.61M |
|
|
|||||
| Total Current Assets | 472.44M | 506.04M | 344.02M | 375.88M | 453.61M |
| Net Property, Plant & Equipment | 44.19M | 47.25M | 71.02M | 71.38M | 72.25M |
| Long-term Investments | -- | -- | 111.72M | 111.30M | 106.34M |
| Goodwill | -- | -- | 111.72M | 111.30M | 106.34M |
| Total Other Intangibles | -- | -- | 28.06M | 28.95M | 23.37M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.52M | 3.68M | 24.79M | 24.83M | 25.98M |
| Total Assets | 539.64M | 556.97M | 579.60M | 612.34M | 681.54M |
|
|
|||||
| Total Accounts Payable | 6.62M | 7.33M | 11.78M | 12.28M | 10.93M |
| Total Accrued Expenses | 22.71M | 21.59M | 13.99M | 21.61M | 21.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.11M | 5.09M | 6.33M | 6.23M | 61.04M |
| Total Finance Division Other Current Liabilities | 73.52M | 64.01M | 24.14M | 25.78M | 27.00M |
| Total Other Current Liabilities | 73.52M | 64.01M | 24.14M | 25.78M | 27.00M |
| Total Current Liabilities | 107.97M | 98.02M | 56.24M | 65.89M | 120.62M |
|
|
|||||
| Total Current Liabilities | 107.97M | 98.02M | 56.24M | 65.89M | 120.62M |
| Long-Term Debt | 299.00K | 299.00K | 299.00K | 299.00K | 299.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.98M | 23.22M | 24.90M | 26.47M | 28.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.74M | 10.88M | 43.57M | 47.96M | 43.15M |
| Total Liabilities | 139.98M | 132.43M | 125.00M | 140.62M | 192.21M |
|
|
|||||
| Common Stock & APIC | 1.73B | 1.72B | 1.71B | 1.70B | 1.69B |
| Retained Earnings | -1.28B | -1.25B | -1.21B | -1.19B | -1.15B |
| Treasury Stock & Other | -46.94M | -48.40M | -45.30M | -45.24M | -47.88M |
| Total Common Equity | 399.66M | 424.54M | 454.60M | 471.72M | 489.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 399.66M | 424.54M | 454.60M | 471.72M | 489.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 399.66M | 424.54M | 454.60M | 471.72M | 489.33M |
|
|
|||||